Pharmaceutical R&D is an exciting field but complex, expensive and uncertain. Researchers can spend years discovering, formulating and testing drugs and treatments, all without the certainty that the final product will gain approval and go to market.
Fortunately, recent advances in artificial intelligence (AI) are helping researchers accelerate the drug discovery process, improve clinical trials and reduce costs.
This guide discusses how AI is supercharging pharmaceutical companies — and how you can leverage the power of AI to improve performance.
.jpg)
Contents
The latest Starmind research report, The High Cost of Inaccessible Knowledge, reveals the extent to which time is wasted and business opportunities are lost, as a result of inadequate and old-fashioned knowledge management practices.
For its research, conducted in July 2022, Starmind engaged with 1,400 respondents in the UK, the US, Switzerland and Germany. Each respondent is a full-time knowledge worker at a company with over 10,000 employees.
This executive summary captures key learnings from the survey, as they pertain to the UK market, and the ways in which business leaders can unlock multiple corporate benefits, ranging from increasing the time spent on the real tasks they need to complete, to more sales, and faster product and service evolution.
Click to access the UK Executive Summary
Sign up to receive latest stats, insights and events
Related posts
